MENU
AVRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AVROBIO (AVRO) Ownership - Who owns AVROBIO?

Avrobio Inc is a clinical-stage gene therapy company... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
100 Technology Square
Phone
+1 617 914-8420
Employees
13
Web
https://www.avrobio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
62.85M
P/E Ratio
2.03
Total Cash
N/A
Projected Growth
N/A
Total Debt
224K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
100 Technology Square
Phone
+1 617 914-8420
Employees
13
Web
https://www.avrobio.com